Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q4 2017 · 10-K
Revenue$240.67M$240.67M+15.8% vs Q4 2016 Net Income$11.09M$11.09M−20.4% vs Q4 2016 EPS Diluted$0.21$0.21−19.2% vs Q4 2016 Gross Profit$130,183,000+10.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$7,424,000−80.4% Free Cash Flowderived$6,382,000−82.7% Margins · derivedGross margin54.1%−2.8 pt vs Q4 2016
Operating margin22.0%−9.4 pt vs Q4 2016
Net margin4.6%−2.1 pt vs Q4 2016
ended Mar 31, 2017 · filed May 17, 2017 · 47 d after period end